tetrahexylammonium has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Dai, Y; Fu, D; Gao, F; Guan, Z; Gutmann, S; Li, J; Li, X; Lv, G; Song, M; Wang, X; Wu, C; Zhang, R | 1 |
1 other study(ies) available for tetrahexylammonium and Leukemia
| Article | Year |
|---|---|
The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance.
Topics: Antibiotics, Antineoplastic; Coated Materials, Biocompatible; Daunorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ferric Compounds; Humans; K562 Cells; Leukemia; Magnetics; Nanoparticles; Quaternary Ammonium Compounds | 2007 |